LU92826I2 - Lubiprostone, incluant les sels pharmaceutiquementacceptables, les esters ou les amides de la lubip rostone - Google Patents

Lubiprostone, incluant les sels pharmaceutiquementacceptables, les esters ou les amides de la lubip rostone Download PDF

Info

Publication number: LU92826I2
Authority: LU; Luxembourg
Prior art keywords: lubip; rostone; lubiprostone; amides; esters
Prior art date: 2001-11-14

Application number

LU92826C

Other languages

English (en)

Original Assignee

Sucampo Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-14

Filing date

2015-09-11

Publication date

2015-11-24

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23293447&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU92826(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2015-09-11 Application filed by Sucampo Ag filed Critical Sucampo Ag

2015-11-24 Publication of LU92826I2 publication Critical patent/LU92826I2/fr

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/15—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing halogen
- C07C53/23—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing halogen containing rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Nutrition Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Pyrane Compounds (AREA)

LU92826C 2001-11-14 2015-09-11 Lubiprostone, incluant les sels pharmaceutiquementacceptables, les esters ou les amides de la lubip rostone LU92826I2 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US33131601P	2001-11-14	2001-11-14

Publications (1)

Publication Number	Publication Date
LU92826I2 true LU92826I2 (fr)	2015-11-24

Family

ID=23293447

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LU92826C LU92826I2 (fr)	2001-11-14	2015-09-11	Lubiprostone, incluant les sels pharmaceutiquementacceptables, les esters ou les amides de la lubip rostone

Country Status (14)

Country	Link
US (3)	US8097653B2 (fr)
EP (2)	EP2298314B1 (fr)
JP (2)	JP4852229B2 (fr)
AR (3)	AR037524A1 (fr)
AT (1)	ATE522218T1 (fr)
BR (1)	BR0214075A (fr)
CA (1)	CA2464420C (fr)
CY (1)	CY1115856T1 (fr)
DK (2)	DK1443938T3 (fr)
ES (2)	ES2524369T3 (fr)
LU (1)	LU92826I2 (fr)
PT (2)	PT2298314E (fr)
TW (1)	TWI331920B (fr)
WO (1)	WO2003041716A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR037524A1 (es)	2001-11-14	2004-11-17	Sucampo Ag	Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
NZ539582A (en) *	2002-10-23	2007-07-27	Sucampo Ag	Prostaglandin compounds for the treatment of obesity
BRPI0317740B8 (pt) *	2002-12-27	2021-05-25	Sucampo Ag	uso do composto 13,14-diidro-15-ceto-16,16-diflúorprostaglandina e1
DE602004030245D1 (de) *	2003-07-03	2011-01-05	Sucampo Ag	Pharmazeutische magensaftresistent überzogene zusammensetzung enthaltend prostaglandin-analoga als chloridkanalöffner
TWI387454B (zh) *	2004-09-02	2013-03-01	蘇坎波公司	治療胃腸道疾病之方法及組成物
US9662325B2 (en)	2005-03-07	2017-05-30	The University Of Chicago	Use of opioid antagonists to attenuate endothelial cell proliferation and migration
ES2714198T3 (es) *	2005-03-07	2019-05-27	Univ Chicago	Uso de antagonistas opioideos para atenuar la proliferación y la migración de células endoteliales
US8524731B2 (en)	2005-03-07	2013-09-03	The University Of Chicago	Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8518962B2 (en)	2005-03-07	2013-08-27	The University Of Chicago	Use of opioid antagonists
US20060281818A1 (en)	2005-03-21	2006-12-14	Sucampo Ag, North Carolina State University	Method for treating mucosal disorders
DK1871380T3 (da) *	2005-04-12	2011-11-21	Sucampo Ag	Kombineret anvendelse af prostaglandinforbindelse og protonpumpeinhibitor til behandlingen af gastrointestinale lidelser
AU2007208632B2 (en) *	2006-01-24	2012-01-19	R-Tech Ueno, Ltd.	Soft-gelatin capsule formulation
MX2008009652A (es)	2006-01-24	2008-11-06	R Tech Ueno Ltd	Composicion farmaceutica que comprende un compuesto biciclico y metodo para estabilizar el compuesto biciclico.
US20090030072A1 (en)	2007-07-03	2009-01-29	Sucampo Ag	Pharmaceutical combination of opioid and prostaglandin compound
US20090012165A1 (en) *	2007-07-03	2009-01-08	Sucampo Ag	Pharmaceutical combination of nsaid and prostaglandin compound
AU2010295464B2 (en) *	2009-09-18	2015-11-26	Merck Sharp & Dohme Corp.	Use of opioid receptor antagonist for gastrointestinal tract disorders
WO2014159679A1 (fr)	2013-03-12	2014-10-02	The United States Of America, As Represented By The Secretary, Department Of Health & Human Services	Procédés pour utiliser la lubiprostone pour absorber un fluide depuis l'espace sous-rétinien

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5350141A (en) *	1976-10-18	1978-05-08	Ono Pharmaceut Co Ltd	Stabilization of prostaglandin and prostaglandin analogues
GB1581886A (en)	1977-05-26	1980-12-31	May & Baker Ltd	Prostanol derivatives
GB2210556B (en) *	1987-10-02	1991-07-17	Ueno Seiyaku Oyo Kenkyujo Kk	The use of 15-keto-16-halo-prostaglandins in cathartic compositions
US5317032A (en) *	1987-10-02	1994-05-31	Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo	Prostaglandin cathartic
JPH0681728B2 (ja)	1987-10-02	1994-10-19	株式会社上野製薬応用研究所	下剤
JP2579193B2 (ja)	1988-07-19	1997-02-05	小野薬品工業株式会社	１６，１６−ジフルオロ−１５−オキソ−１５−デオキシｐｇｅ誘導体
CA2027814C (fr) *	1989-10-20	1996-07-30	Ryuji Ueno	Traitement d'une maladie hepatobiliaire a base de composes 5-cetoprostaglandin
CA2030345C (fr) *	1989-11-22	1998-12-08	Ryuji Ueno	Utilisation d'un compose de 15-ceto-prostaglandines pour l'amelioration des fonctions encephaliques
CA2030344C (fr) *	1989-11-22	2000-04-18	Ryuji Ueno	Traitement de troubles pulmonaires a l'aide de composes de 15-ceto-prostaglandines
CA2030346C (fr)	1989-11-22	2000-04-11	Ryuji Ueno	Traitement de troubles cardiaques a l'aide de composes de 15-ceto-prostaglandines
DE69130586T2 (de)	1990-05-01	1999-06-17	R-Tech Ueno, Ltd., Osaka	Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
CA2046069C (fr)	1990-07-10	2002-04-09	Ryuji Ueno	Traitement des maladies inflammatoires au moyen de composes de 15-cetoprostaglandine
JP2938579B2 (ja)	1990-12-15	1999-08-23	株式会社上野製薬応用研究所	消化管壁保護剤
ES2093774T3 (es) *	1991-03-14	1997-01-01	R Tech Ueno Ltd	Estimulacion de la curacion de heridas con un compuesto 15-cetoprostaglandina.
ES2118842T3 (es) *	1992-02-04	1998-10-01	Eisai Co Ltd	Derivados del acido aminobenzoico.
JP3183615B2 (ja) *	1994-06-03	2001-07-09	株式会社アールテック・ウエノ	肝・胆道系疾患処置剤
CA2150287C (fr) *	1994-06-03	2004-08-10	Ryuji Ueno	Agent therapeutique pour les affections hepatobiliaires
DK0857718T3 (da) *	1996-06-10	2002-12-16	Sucampo Ag	Endothelinantagonist
DE19717005A1 (de) *	1997-04-23	1998-10-29	Kennametal Inc	Spannfutter für Rundlaufwerkzeuge
AU739343B2 (en) *	1997-11-28	2001-10-11	Sucampo Ag	Endothelin antagonist
US6492417B1 (en)	1997-12-22	2002-12-10	Alcon Manufacturing, Ltd.	11-deoxy-16-fluoro-PGF2α analogs as FP receptor antagonists
AR026046A1 (es) *	1999-10-15	2002-12-26	R Tech Ueno Ltd	NUEVA COMPOSICIoN Y MÉTODO PARA ESTABILIZAR LA MISMA
ATE433754T1 (de)	2000-04-06	2009-07-15	Sucampo Ag	Gallensäurefördernde zusammensetzung für lebertransplantation welche ein 15-keto prostaglandin enthält
US6414016B1 (en) *	2000-09-05	2002-07-02	Sucampo, A.G.	Anti-constipation composition
TWI302100B (en) *	2001-05-02	2008-10-21	Sucampo Ag	Composition for treating drug-induced constipation
ATE387204T1 (de)	2001-05-18	2008-03-15	Sucampo Ag	Zusammensetzung mit induzierendem kathartischen effekt
BR0212233A (pt) *	2001-08-31	2004-10-05	Sucampo Ag	Abridor de canal de cloreto
AR037524A1 (es)	2001-11-14	2004-11-17	Sucampo Ag	Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
US7732487B2 (en)	2001-11-19	2010-06-08	Sucampo Ag	Method for treating a disease or condition responsive to opening of C1C-2 channel
BRPI0317740B8 (pt) *	2002-12-27	2021-05-25	Sucampo Ag	uso do composto 13,14-diidro-15-ceto-16,16-diflúorprostaglandina e1

2002
- 2002-11-13 AR ARP020104349A patent/AR037524A1/es not_active Application Discontinuation
- 2002-11-13 TW TW091133227A patent/TWI331920B/zh not_active IP Right Cessation
- 2002-11-14 DK DK02780083.8T patent/DK1443938T3/da active
- 2002-11-14 DK DK10010211.0T patent/DK2298314T3/en active
- 2002-11-14 BR BR0214075-6A patent/BR0214075A/pt not_active Application Discontinuation
- 2002-11-14 WO PCT/JP2002/011862 patent/WO2003041716A1/fr not_active Ceased
- 2002-11-14 PT PT100102110T patent/PT2298314E/pt unknown
- 2002-11-14 JP JP2003543603A patent/JP4852229B2/ja not_active Expired - Lifetime
- 2002-11-14 PT PT02780083T patent/PT1443938E/pt unknown
- 2002-11-14 US US10/293,516 patent/US8097653B2/en not_active Expired - Lifetime
- 2002-11-14 AT AT02780083T patent/ATE522218T1/de active
- 2002-11-14 CA CA2464420A patent/CA2464420C/fr not_active Expired - Lifetime
- 2002-11-14 EP EP10010211.0A patent/EP2298314B1/fr not_active Expired - Lifetime
- 2002-11-14 ES ES10010211.0T patent/ES2524369T3/es not_active Expired - Lifetime
- 2002-11-14 EP EP02780083A patent/EP1443938B1/fr not_active Expired - Lifetime
- 2002-11-14 ES ES02780083T patent/ES2368729T3/es not_active Expired - Lifetime
2011
- 2011-05-25 JP JP2011117231A patent/JP2011201905A/ja active Pending
- 2011-12-20 US US13/330,942 patent/US8389542B2/en not_active Expired - Fee Related
2013
- 2013-01-30 US US13/754,138 patent/US20130143958A1/en not_active Abandoned
2014
- 2014-11-28 CY CY20141100997T patent/CY1115856T1/el unknown
- 2014-12-30 AR ARP140104956A patent/AR098997A2/es unknown
2015
- 2015-09-11 LU LU92826C patent/LU92826I2/fr unknown
2019
- 2019-03-21 AR ARP190100714A patent/AR117404A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
AR098997A2 (es)	2016-06-22
JP2011201905A (ja)	2011-10-13
TWI331920B (en)	2010-10-21
BR0214075A (pt)	2004-09-28
PT1443938E (pt)	2011-09-27
JP4852229B2 (ja)	2012-01-11
ES2368729T3 (es)	2011-11-21
DK2298314T3 (en)	2014-12-01
HK1155649A1 (en)	2012-05-25
CY1115856T1 (el)	2017-01-25
DK1443938T3 (da)	2011-09-26
AR037524A1 (es)	2004-11-17
JP2005513014A (ja)	2005-05-12
EP1443938A1 (fr)	2004-08-11
US20120088824A1 (en)	2012-04-12
ATE522218T1 (de)	2011-09-15
WO2003041716A1 (fr)	2003-05-22
US8389542B2 (en)	2013-03-05
EP1443938B1 (fr)	2011-08-31
US20130143958A1 (en)	2013-06-06
AR117404A2 (es)	2021-08-04
PT2298314E (pt)	2014-12-03
CA2464420C (fr)	2011-12-13
ES2524369T3 (es)	2014-12-05
EP2298314B1 (fr)	2014-09-03
EP2298314A1 (fr)	2011-03-23
TW200300091A (en)	2003-05-16
CA2464420A1 (fr)	2003-05-22
US8097653B2 (en)	2012-01-17
US20030119898A1 (en)	2003-06-26

Publication	Publication Date	Title
LU92826I2 (fr)	2015-11-24	Lubiprostone, incluant les sels pharmaceutiquementacceptables, les esters ou les amides de la lubip rostone
FR2828408B1 (fr)	2007-06-29	Procede de formation d'implant
DE10085137T1 (de)	2002-11-07	Chirurgischer Sensor
PL364223A1 (en)	2004-12-13	Pharmaceutical salts
DE60126038D1 (de)	2007-03-08	Chirurgisches Ultraschallsystem
IL161736A0 (en)	2005-11-20	Novel benzophenone derivatives or salts thereof
GB0101990D0 (en)	2001-03-14	Surgical system
NO20040198L (no)	2004-02-19	Dolastatin 10 derivater
IT1317741B1 (it)	2003-07-15	Metodo per la preparazione di 5-cianoftalide.
FR2815535B1 (fr)	2003-01-24	Implant pediculaire
IT1319251B1 (it)	2003-09-26	Metodo per la preparazione di 5-carbossiftalide.
FR2833596B1 (fr)	2005-02-18	Procede de preparation de derives d'echinocandine
FI20000368L (fi)	2001-08-18	Menetelmä pään alueen kuvaamiseksi
ITMI20011503A0 (it)	2001-07-13	Procedimeno per sterilizzare oggetti
FR2818979B1 (fr)	2003-05-30	Procede de preparation d'imidaclopride
DE60029273D1 (de)	2006-08-24	Titan-Tinoxidfilme
MA27240A1 (fr)	2005-03-01	Derives d'imidazoquinoleine
GB2394899B (en)	2004-11-03	Ophtalmic tissue barrier
EP1452597A4 (fr)	2006-09-20	Procede d'activation de proteine
MXPA03003346A (es)	2003-06-19	Metodo para la purificacion de pravastatina o una sal farmacologicamente aceptable de la misma.
EP1295864A4 (fr)	2005-12-28	Procede de preparation de 1,5-diaminonaphtalenes
DE50200325D1 (de)	2004-05-13	Gewinderollkopf
ITRM20010332A0 (it)	2001-06-11	Vaccini a subunita' e procedimenti per la loro produzione.
ITMI992457A0 (it)	1999-11-25	Procedimento per la preparazione di (s)-n-terbutil-1,2,3,4-tetraidrois ochinolin-3-carbossiammide
ITRM990762A0 (it)	1999-12-17	Procedimento per la preparazione di filati ondee o compensina.